Concepedia

Jennifer Robertson

JR

Statistics

Publications

11

Citations

341

H-Index

11

Active since

2013

Affiliations

NovaBiotics (United Kingdom)(Current)

Jennifer Robertson is an author at NovaBiotics (United Kingdom) specializing in pharmacology, life sciences, and cystic fibrosis pharmacotherapy.

Publications per year

2013–2020

11

Publications

11

Cysteamine (Lynovex®), a novel mucoactive antimicrobial & antibiofilm agent for the treatment of cystic fibrosis

Cédric Charrier, Catherine Rodger, Jennifer Robertson et al. · Orphanet Journal of Rare Diseases · 2014 · 58 citations · Full text

, , +17

NP213 (Novexatin®): A unique therapy candidate for onychomycosis with a differentiated safety and efficacy profile

Derry K. Mercer, Jennifer Robertson, Lorna Miller et al. · Medical Mycology · 2020 · 57 citations · Full text

, , +17

Improved Methods for Assessing Therapeutic Potential of Antifungal Agents against Dermatophytes and Their Application in the Development of NP213, a Novel Onychomycosis Therapy Candidate

Derry K. Mercer, C.S. Stewart, Lorna Miller et al. · Antimicrobial Agents and Chemotherapy · 2019 · 36 citations · Full text

, , +17

A Prodrug Approach to the Use of Coumarins as Potential Therapeutics for Superficial Mycoses

Derry K. Mercer, Jennifer Robertson, Kristine N. Wright et al. · PLoS ONE · 2013 · 35 citations · Full text

, , +14

Cysteamine as a Future Intervention in Cystic Fibrosis Against Current and Emerging Pathogens: A Patient-based ex vivo Study Confirming its Antimicrobial and Mucoactive Potential in Sputum

Graham Devereux, Douglas Fraser‐Pitt, Jennifer Robertson et al. · EBioMedicine · 2015 · 35 citations · Full text

, , +10

1–5 of 11